What's new

Human medicines European public assessment report (EPAR): Orgovyx, relugolix, Date of authorisation: 29/04/2022, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Orgovyx, relugolix, Date of authorisation: 29/04/2022, Revision: 12, Status: Authorised

Jun 24, 2025 - 15:10
 0
Human medicines European public assessment report (EPAR): Orgovyx, relugolix, Date of authorisation: 29/04/2022, Revision: 12, Status: Authorised
Human medicines European public assessment report (EPAR): Orgovyx, relugolix, Date of authorisation: 29/04/2022, Revision: 12, Status: Authorised
Read More

Tags:

Previous Article

STAT+: Pharmalittle: We’re reading about a top FDA official leaving, Sen. Cassid...

Next Article

EMEA-003112-PIP01-21-M01

Related Posts

EMA/PDCO summary report on the review of the list of gr...

Jun 3, 2025  0

Overview of comments received on ICH E6(R3) guideline f...

May 23, 2025  0

Human medicines European public assessment report (EPAR): Adempas, riociguat, Date of authorisation: 27/03/2014, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

May 19, 2025  0